AT1 and AT2 receptor in the kidney: role in health and disease.
Semin Nephrol. 2004 Mar;24(2):93-100
Oxidative stress in hypertension and chronic kidney disease: role of angiotensin II.
Semin Nephrol. 2004 Mar;24(2):101-14
AT1 receptor heterodimers and angiotensin II responsiveness in preeclampsia.
Semin Nephrol. 2004 Mar;24(2):115-9
Angiotensin II receptor type 1 expression in erythroid progenitors: Implications for the pathogenesis of postrenal transplant erythrocytosis.
Semin Nephrol. 2004 Mar;24(2):120-30
Changes in glomerular perm-selectivity induced by angiotensin II imply podocyte dysfunction and slit diaphragm protein rearrangement.
Semin Nephrol. 2004 Mar;24(2):131-40
Impact of renin angiotensin system blockade on renal function in health and disease: an end or a beginning?
Semin Nephrol. 2004 Mar;24(2):141-6
Angiotensin receptor blockers in diabetic nephropathy: renal and cardiovascular end points.
Semin Nephrol. 2004 Mar;24(2):147-57
Angiotensin-converting enzyme inhibition and angiotensin II antagonism in nondiabetic chronic nephropathies.
Semin Nephrol. 2004 Mar;24(2):158-67
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic renal disease: safety issues.
Semin Nephrol. 2004 Mar;24(2):168-75